There are facts that cannabis consumers have repeated until they were accepted as objective truth. Most people agree that sativas are energetic, while indicas make them more sleepy or lethargic. Others might claim that an equal dose of THC and CBD is best for pain.

Cannabis tech and wellness brand Jointly helps people track how they use weed products for wellness. Co-founder and CEO David Kooi recently told GreenState that not all of the app data aligns with cannabis culture “facts.”

RELATED: AI is perfecting the cannabis shopping experience

“Product choice accounts for 26 percent of the cannabis experience and dose accounts for 25 percent, while the remaining 49 percent is the result of factors like setting, hydration, exercise, diet, time since last dose, and more. It’s not just what you use but how you use it,” Kooi said.

The Jointly app serves as a consumption journal, but one with the ability to connect specific brands’ strains and products. All of that shared information paints a more detailed picture of what cannabis and its vital compounds might be capable of.

Correcting common cannabis misnomers

People have been discrediting indica and sativa labels for some time. Dr. Ethan Russo has long been a proponent of judging weed based on terpenes rather than the terms mentioned above. Jointly data supports Russo’s theories, showing that these names aren’t all they are cracked up to be. App users set an intention for their sesh before explaining the consumption products and methods.

Sativa strains and concentrates have been offered as a more uplifting and clear-headed option than those labeled indica. However, experiences shared in the Jointly app tell another tale. The average sativa variety scores 12 percent higher than the average indica in the “Energize” category, but 47 percent of Indica experiences outperformed the average sativa.

This is echoed in the “Exercise” category. People had a 17 percent higher rating for sativas on average, but indica strains outperformed sativa ones 41 percent of the time. As for “Focus,” sativas were six percent more popular than indicas, but 47.5 percent of users had success focusing with these “more relaxing” strain options. The same goes for creativity. Many tout sativas as creative strains, but 47 percent of indica experience outperformed sativas in this category.

While many believe sativas are the answer for every mental task, anecdotal data shows that there is more to the story.

“These above 4 points show that strain type alone is insufficient to predict the quality or effectiveness of a cannabis experience without considering other factors. The same can be said for specific cannabinoids or terpenes,” said Kooi.

Indica and sativa are just one piece of a vast cannabis vocabulary puzzle, part of which is full of acronyms. THC, CBD, CBN, and other compounds have been making headlines for their supposed benefits for sleep and pain. Much like the world of strain labels, there is much left to learn regarding what these cannabinoids are capable of.

RELATED: Smoking weed could be bad for you, this may help

Cannabinoids could be more useful than we think

The plant has brought so much relief with so little scientific basis that consumers are starving for more cannabis research. Unfortunately, there has been a research scarcity for generations. Because of this, as new studies emerge, the culture often quickly adopts them as reality. While there is no reason to imply that theories posed in research papers are incorrect, assume there is more to the story.

One common stoner fact is that CBN helps people sleep, but the cannabinoid possibilities extend far beyond solely slumber. According to Jointly users, CBN could also be a valuable tool for stress relief and pain symptoms. Most turn to CBD or a combination of that and THC when experiencing pain and tension, but even that journey has its misconceptions.

People recording experiences using cannabis products to relieve pain and/or stress shared that the commonly suggested 1:1 ratio of 10 milligrams (mg) of THC to 10 mg CBD does not work as well as 20 mg of THC alone. However, massively upping the CBD from 50 to 100 mg with 10 mg THC helped encourage relaxation and relief better than both of the other options.

“CBD doses under 15mg show no impact on average effectiveness for these goals, but doses of 50mg or more increase effectiveness by 10-20 percent, though most of the effectiveness is still driven by THC and other non-product factors,” Kooi explained.

This information is helpful for those exploring the many facets of cannabis possibility, but also an indicator of why weed doesn’t translate easily into Western medicine. It also emphasizes a need for cannabis sommeliers who are trained specifically on the plant–at least until medical training catches up to the industry.

Weed lessons keep coming

Every month, the world learns something new about how the cannabis plant interacts with the human body. For good or bad, research continues revealing what weed is capable of–and this data shows how much is left to learn.

The best way to know how each strain or product will impact an individual is to keep a diary and shop based on personal experience. Until the research grows, there will be an element of “choose your own adventure” with weed products.